Synthetic Disaggregators Enhance Central‐Peripheral Amyloid‐β Clearance in Alzheimer's Disease
Advanced Materials · 2026-02 · 38 (11)
DOI: 10.1002/adma.202520002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 09.01.2026. Verfasst von Chunwei Tang und 23 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Shandong Key Laboratory of Targeted Drug …. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides, Protein Aggregates. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Fundamental Research Funds of Shandong Province.
Themen: Demenz
Abstract (Originalsprache)
Pathogenic amyloid‐β (Aβ) accumulation defines Alzheimer's disease (AD), directly inflicting neuronal damage and driving chronic neuroinflammation. While both central microglia and peripheral macrophages are critical for Aβ clearance, their functional impairment in AD inexorably leads to escalating Aβ burden and disease progression. We here report an in situ engineered synthetic Aβ disaggregator (SAD) delivered to macrophages via neuroprotective DHA‐based lipid nanoparticles (DLNPs). This platform transcends current therapeutic limitations by not only potently dismantling neurotoxic Aβ aggregates but also by fundamentally reprogramming peripheral macrophages to enhance Aβ clearance. Specifically, our results demonstrate that DLNPs effectively reprogram peripheral macrophages to produce and secrete cerebral‐penetrating SAD both in vitro and in vivo. The SAD can promote cerebral Aβ disaggregation, thereby inhibiting neuroinflammatory pathology progression. Moreover, the DLNPs efficiently reprogram the peripheral macrophages to enhance phagocytosis, further facilitating drainage of Aβ and reducing cerebral Aβ accumulation in mouse models. Collectively, these findings uncover a dual‐action mechanism of SAD through the synergistic interplay of direct Aβ disaggregation and enhanced macrophage‐mediated clearance. In sum, our findings establish that the central‐peripheral targeting therapeutic strategy significantly reversed AD pathology, highlighting the therapeutic potential of mRNA‐based in situ fusion protein in AD treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Shandong Key Laboratory of Targeted Drug Delivery and Advanced Pharmaceutics, School of Pharmaceutical Sciences…
- Department of Urology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
- Department of Research, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
- Department of Pharmacy, Dongying People's Hospital, Dongying, Shandong, China.
- Institute of Brain and Brain-Inspired Science, Shandong Key Laboratory of Brain Health and Function Remodeling, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
ORCID-Profile: Xinyi Jiang
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Fundamental Research Funds of Shandong Province
- Natural Science Foundation of Shandong Province
- China Postdoctoral Science Foundation
- Shandong Provincial Laboratory Project
- Taishan Scholar Foundation of Shandong Province
- Key R&D Program of Shandong Province
Zitieren
APA
Tang, C., Han, K., Wen, X., Zhang, J., Sun, W., Yue, X., Shi, L., Liu, Z., Zhao, J., Yan, C., Liu, M., Yao, Z., Kong, Z., Liu, Y., Fu, Z., Zhao, X., Yang, Z., Han, M., Chen, C., …, & Jiang, X. (2026). Synthetic Disaggregators Enhance Central‐Peripheral Amyloid‐β Clearance in Alzheimer's Disease. Advanced Materials, 38(11). https://doi.org/10.1002/adma.202520002
Vancouver
Tang C, Han K, Wen X, Zhang J, Sun W, Yue X, et al. Synthetic Disaggregators Enhance Central‐Peripheral Amyloid‐β Clearance in Alzheimer's Disease. Advanced Materials. 2026;38(11). doi:10.1002/adma.202520002
BibTeX
@article{Tang2026,
author = {Tang, Chunwei and Han, Kun and Wen, Xin and Zhang, Jing and Sun, Weiyi and Yue, Xiao and Shi, Lihui and Liu, Zejuan and Zhao, Jianxiong and Yan, Chongzheng and Liu, Miaoyan and Yao, Zichao and Kong, Zhichao and Liu, Ying and Fu, Zhipeng and Zhao, Xiaotian and Yang, Zhenmei and Han, Maosen and Chen, Chen and Xing, Zhaoquan and Zhou, Xiaoming and Yang, Fei and Zhang, Yulin and Jiang, Xinyi},
title = {Synthetic Disaggregators Enhance Central‐Peripheral Amyloid‐β Clearance in Alzheimer's Disease},
journal = {Advanced Materials},
year = {2026},
volume = {38},
number = {11},
doi = {10.1002/adma.202520002}
}
EUVIMED